{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T00:50:26Z","timestamp":1794358226575,"version":"4.9.0"},"reference-count":38,"publisher":"American Association for Cancer Research (AACR)","issue":"3","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cyclin-dependent kinase 6 (CDK6) promotes cell cycle progression and is overexpressed in human lymphoid malignancies. To determine the role of CDK6 in development and tumorigenesis, we generated and analyzed knockout mice. Cdk6-deficient mice show pronounced thymic atrophy due to reduced proliferative fractions and concomitant transitional blocks in the double-negative stages. Using the OP9-DL1 system to deliver temporally controlled Notch receptor\u2013dependent signaling, we show that CDK6 is required for Notch-dependent survival, proliferation, and differentiation. Furthermore, CDK6-deficient mice were resistant to lymphomagenesis induced by active Akt, a downstream target of Notch signaling. These results show a critical requirement for CDK6 in Notch\/Akt-dependent T-cell development and tumorigenesis and strongly support CDK6 as a specific therapeutic target in human lymphoid malignancies. [Cancer Res 2009;69(3):810\u20138]<\/jats:p>","DOI":"10.1158\/0008-5472.can-08-2473","type":"journal-article","created":{"date-parts":[[2009,1,20]],"date-time":"2009-01-20T20:45:30Z","timestamp":1232484330000},"page":"810-818","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":105,"title":["A Requirement for Cyclin-Dependent Kinase 6 in Thymocyte Development and Tumorigenesis"],"prefix":"10.1158","volume":"69","author":[{"given":"Miaofen G.","family":"Hu","sequence":"first","affiliation":[{"name":"1Molecular Oncology Research Institute, Tufts Medical Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Deshpande","sequence":"additional","affiliation":[{"name":"4Dental Research Institute, University of California-Los Angeles, Los Angeles, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Enos","sequence":"additional","affiliation":[{"name":"1Molecular Oncology Research Institute, Tufts Medical Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daqin","family":"Mao","sequence":"additional","affiliation":[{"name":"1Molecular Oncology Research Institute, Tufts Medical Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth A.","family":"Hinds","sequence":"additional","affiliation":[{"name":"1Molecular Oncology Research Institute, Tufts Medical Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-fu","family":"Hu","sequence":"additional","affiliation":[{"name":"2Department of Pathology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Chang","sequence":"additional","affiliation":[{"name":"1Molecular Oncology Research Institute, Tufts Medical Center;"},{"name":"3Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuyan","family":"Guo","sequence":"additional","affiliation":[{"name":"1Molecular Oncology Research Institute, Tufts Medical Center;"},{"name":"5Department of Biology, Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marei","family":"Dose","sequence":"additional","affiliation":[{"name":"1Molecular Oncology Research Institute, Tufts Medical Center;"},{"name":"6Department of Medicine, Committee on Immunology, University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changchuin","family":"Mao","sequence":"additional","affiliation":[{"name":"1Molecular Oncology Research Institute, Tufts Medical Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip N.","family":"Tsichlis","sequence":"additional","affiliation":[{"name":"1Molecular Oncology Research Institute, Tufts Medical Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fotini","family":"Gounari","sequence":"additional","affiliation":[{"name":"1Molecular Oncology Research Institute, Tufts Medical Center;"},{"name":"6Department of Medicine, Committee on Immunology, University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip W.","family":"Hinds","sequence":"additional","affiliation":[{"name":"1Molecular Oncology Research Institute, Tufts Medical Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2009,1,29]]},"reference":[{"key":"2022061701380806600_B1","doi-asserted-by":"crossref","unstructured":"Wilson A, MacDonald HR, Radtke F. Notch 1-deficient common lymphoid precursors adopt a B cell fate in the thymus. J Exp Med\u20082001; 194: 1003\u201312.","DOI":"10.1084\/jem.194.7.1003"},{"key":"2022061701380806600_B2","doi-asserted-by":"crossref","unstructured":"Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science\u20081999; 284: 770\u20136.","DOI":"10.1126\/science.284.5415.770"},{"key":"2022061701380806600_B3","doi-asserted-by":"crossref","unstructured":"Radtke F, Wilson A, Stark G, et al. Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity\u20081999; 10: 547\u201358.","DOI":"10.1016\/S1074-7613(00)80054-0"},{"key":"2022061701380806600_B4","doi-asserted-by":"crossref","unstructured":"Schmitt TM, Zuniga-Pflucker JC. Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro. Immunity\u20082002; 17: 749\u201356.","DOI":"10.1016\/S1074-7613(02)00474-0"},{"key":"2022061701380806600_B5","doi-asserted-by":"crossref","unstructured":"Aster JC, Pear WS, Blacklow SC. Notch signaling in leukemia. Annu Rev Pathol\u20082008; 3: 587\u2013613.","DOI":"10.1146\/annurev.pathmechdis.3.121806.154300"},{"key":"2022061701380806600_B6","doi-asserted-by":"crossref","unstructured":"Ciofani M, Zuniga-Pflucker JC. Notch promotes survival of pre-T cells at the \u03b2-selection checkpoint by regulating cellular metabolism. Nat Immunol\u20082005; 6: 881\u20138.","DOI":"10.1038\/ni1234"},{"key":"2022061701380806600_B7","doi-asserted-by":"crossref","unstructured":"Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev\u20081999; 13: 1501\u201312.","DOI":"10.1101\/gad.13.12.1501"},{"key":"2022061701380806600_B8","doi-asserted-by":"crossref","unstructured":"Grossel MJ, Hinds PW. From cell cycle to differentiation: an expanding role for cdk6. Cell Cycle\u20082006; 5: 266\u201370.","DOI":"10.4161\/cc.5.3.2385"},{"key":"2022061701380806600_B9","doi-asserted-by":"crossref","unstructured":"Pavletich NP. Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors. J Mol Biol\u20081999; 287: 821\u20138.","DOI":"10.1006\/jmbi.1999.2640"},{"key":"2022061701380806600_B10","doi-asserted-by":"crossref","unstructured":"Sicinska E, Aifantis I, Le Cam L, et al. Requirement for cyclin D3 in lymphocyte development and T cell leukemias. Cancer Cell\u20082003; 4: 451\u201361.","DOI":"10.1016\/S1535-6108(03)00301-5"},{"key":"2022061701380806600_B11","doi-asserted-by":"crossref","unstructured":"Rane SG, Dubus P, Mettus RV, et al. Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in \u03b2-islet cell hyperplasia. Nat Genet\u20081999; 22: 44\u201352.","DOI":"10.1038\/8751"},{"key":"2022061701380806600_B12","doi-asserted-by":"crossref","unstructured":"Martin A, Odajima J, Hunt SL, et al. Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1). Cancer Cell\u20082005; 7: 591\u20138.","DOI":"10.1016\/j.ccr.2005.05.006"},{"key":"2022061701380806600_B13","doi-asserted-by":"crossref","unstructured":"Malumbres M, Sotillo R, Santamaria D, et al. Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6. Cell\u20082004; 118: 493\u2013504.","DOI":"10.1016\/j.cell.2004.08.002"},{"key":"2022061701380806600_B14","doi-asserted-by":"crossref","unstructured":"Della Ragione F, Borriello A, Mastropietro S, et al. Expression of G1-phase cell cycle genes during hematopoietic lineage. Biochem Biophys Res Commun\u20081997; 231: 73\u20136.","DOI":"10.1006\/bbrc.1997.5938"},{"key":"2022061701380806600_B15","unstructured":"Chilosi M, Doglioni C, Yan Z, et al. Differential expression of cyclin-dependent kinase 6 in cortical thymocytes and T-cell lymphoblastic lymphoma\/leukemia. Am J Pathol\u20081998; 152: 209\u201317."},{"key":"2022061701380806600_B16","doi-asserted-by":"crossref","unstructured":"Lien HC, Lin CW, Huang PH, Chang ML, Hsu SM. Expression of cyclin-dependent kinase 6 (cdk6) and frequent loss of CD44 in nasal-nasopharyngeal NK\/T-cell lymphomas: comparison with CD56-negative peripheral T-cell lymphomas. Lab Invest\u20082000; 80: 893\u2013900.","DOI":"10.1038\/labinvest.3780093"},{"key":"2022061701380806600_B17","doi-asserted-by":"crossref","unstructured":"Nagel S, Leich E, Quentmeier H, et al. Amplification at 7q22 targets cyclin-dependent kinase 6 in T-cell lymphoma. Leukemia\u20082008; 22: 387\u201392.","DOI":"10.1038\/sj.leu.2405028"},{"key":"2022061701380806600_B18","doi-asserted-by":"crossref","unstructured":"Schwartz R, Engel I, Fallahi-Sichani M, Petrie HT, Murre C. Gene expression patterns define novel roles for E47 in cell cycle progression, cytokine-mediated signaling, and T lineage development. Proc Natl Acad Sci U S A\u20082006; 103: 9976\u201381.","DOI":"10.1073\/pnas.0603728103"},{"key":"2022061701380806600_B19","doi-asserted-by":"crossref","unstructured":"Hu MG, Hu GF, Kim Y, et al. Role of p12(CDK2-AP1) in transforming growth factor-\u03b21-mediated growth suppression. Cancer Res\u20082004; 64: 490\u20139.","DOI":"10.1158\/0008-5472.CAN-03-2284"},{"key":"2022061701380806600_B20","doi-asserted-by":"crossref","unstructured":"Gounari F, Chang R, Cowan J, et al. Loss of adenomatous polyposis coli gene function disrupts thymic development. Nat Immunol\u20082005; 6: 800\u20139.","DOI":"10.1038\/ni1228"},{"key":"2022061701380806600_B21","doi-asserted-by":"crossref","unstructured":"Gounari F, Aifantis I, Martin C, et al. Tracing lymphopoiesis with the aid of a pT\u03b1-controlled reporter gene. Nat Immunol\u20082002; 3: 489\u201396.","DOI":"10.1038\/ni778"},{"key":"2022061701380806600_B22","doi-asserted-by":"crossref","unstructured":"Veiga-Fernandes H, Rocha B. High expression of active CDK6 in the cytoplasm of CD8 memory cells favors rapid division. Nat Immunol\u20082004; 5: 31\u20137.","DOI":"10.1038\/ni1015"},{"key":"2022061701380806600_B23","doi-asserted-by":"crossref","unstructured":"Tsutsui T, Hesabi B, Moons DS, et al. Targeted disruption of CDK4 delays cell cycle entry with enhanced p27(Kip1) activity. Mol Cell Biol\u20081999; 19: 7011\u20139.","DOI":"10.1128\/MCB.19.10.7011"},{"key":"2022061701380806600_B24","doi-asserted-by":"crossref","unstructured":"Godfrey DI, Zlotnik A. Control points in early T-cell development. Immunol Today\u20081993; 14: 547\u201353.","DOI":"10.1016\/0167-5699(93)90186-O"},{"key":"2022061701380806600_B25","doi-asserted-by":"crossref","unstructured":"Schwarz BA, Bhandoola A. Circulating hematopoietic progenitors with T lineage potential. Nat Immunol\u20082004; 5: 953\u201360.","DOI":"10.1038\/ni1101"},{"key":"2022061701380806600_B26","doi-asserted-by":"crossref","unstructured":"Diehl JA, Cheng M, Roussel MF, Sherr CJ. Glycogen synthase kinase-3\u03b2 regulates cyclin D1 proteolysis and subcellular localization. Genes Dev\u20081998; 12: 3499\u2013511.","DOI":"10.1101\/gad.12.22.3499"},{"key":"2022061701380806600_B27","doi-asserted-by":"crossref","unstructured":"Muise-Helmericks RC, Grimes HL, Bellacosa A, Malstrom SE, Tsichlis PN, Rosen N. Cyclin D expression is controlled post-transcriptionally via a phosphatidylinositol 3-kinase\/Akt-dependent pathway. J Biol Chem\u20081998; 273: 29864\u201372.","DOI":"10.1074\/jbc.273.45.29864"},{"key":"2022061701380806600_B28","doi-asserted-by":"crossref","unstructured":"Malstrom S, Tili E, Kappes D, Ceci JD, Tsichlis PN. Tumor induction by an Lck-MyrAkt transgene is delayed by mechanisms controlling the size of the thymus. Proc Natl Acad Sci U S A\u20082001; 98: 14967\u201372.","DOI":"10.1073\/pnas.231467698"},{"key":"2022061701380806600_B29","doi-asserted-by":"crossref","unstructured":"Nicholson KM, Anderson NG. The protein kinase B\/Akt signalling pathway in human malignancy. Cell Signal\u20082002; 14: 381\u201395.","DOI":"10.1016\/S0898-6568(01)00271-6"},{"key":"2022061701380806600_B30","doi-asserted-by":"crossref","unstructured":"Zweidler-McKay PA, Pear WS. Notch and T cell malignancy. Semin Cancer Biol\u20082004; 14: 329\u201340.","DOI":"10.1016\/j.semcancer.2004.04.012"},{"key":"2022061701380806600_B31","doi-asserted-by":"crossref","unstructured":"Alessi DR, Andjelkovic M, Caudwell B, et al. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J\u20081996; 15: 6541\u201351.","DOI":"10.1002\/j.1460-2075.1996.tb01045.x"},{"key":"2022061701380806600_B32","doi-asserted-by":"crossref","unstructured":"Mao C, Tili EG, Dose M, et al. Unequal contribution of Akt isoforms in the double-negative to double-positive thymocyte transition. J Immunol\u20082007; 178: 5443\u201353.","DOI":"10.4049\/jimmunol.178.9.5443"},{"key":"2022061701380806600_B33","doi-asserted-by":"crossref","unstructured":"Lawlor MA, Alessi DR. PKB\/Akt: a key mediator of cell proliferation, survival and insulin responses? J Cell Sci\u20082001; 114: 2903\u201310.","DOI":"10.1242\/jcs.114.16.2903"},{"key":"2022061701380806600_B34","doi-asserted-by":"crossref","unstructured":"Nie L, Xu M, Vladimirova A, Sun XH. Notch-induced E2A ubiquitination and degradation are controlled by MAP kinase activities. EMBO J\u20082003; 22: 5780\u201392.","DOI":"10.1093\/emboj\/cdg567"},{"key":"2022061701380806600_B35","doi-asserted-by":"crossref","unstructured":"Talora C, Campese AF, Bellavia D, et al. Pre-TCR-triggered ERK signalling-dependent downregulation of E2A activity in Notch3-induced T-cell lymphoma. EMBO Rep\u20082003; 4: 1067\u201372.","DOI":"10.1038\/sj.embor.7400013"},{"key":"2022061701380806600_B36","doi-asserted-by":"crossref","unstructured":"Engel I, Murre C. Disruption of pre-TCR expression accelerates lymphomagenesis in E2A-deficient mice. Proc Natl Acad Sci U S A\u20082002; 99: 11322\u20137.","DOI":"10.1073\/pnas.162373999"},{"key":"2022061701380806600_B37","doi-asserted-by":"crossref","unstructured":"Reizis B, Leder P. Direct induction of T lymphocyte-specific gene expression by the mammalian Notch signaling pathway. Genes Dev\u20082002; 16: 295\u2013300.","DOI":"10.1101\/gad.960702"},{"key":"2022061701380806600_B38","doi-asserted-by":"crossref","unstructured":"Boyer LA, Lee TI, Cole MF, et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell\u20082005; 122: 947\u201356.","DOI":"10.1016\/j.cell.2005.08.020"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/3\/810\/2622118\/810.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/3\/810\/2622118\/810.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T04:34:45Z","timestamp":1655440485000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/69\/3\/810\/552895\/A-Requirement-for-Cyclin-Dependent-Kinase-6-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,29]]},"references-count":38,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2009,1,29]]},"published-print":{"date-parts":[[2009,2,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-08-2473","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22380095","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22380095.v1","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6499448","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6499448.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,29]]}}}